Our partners

An interdisciplinary consortium

DARTBAC is an interdisciplinary, 23 partner consortium consisting of
(a) academic partners with expertise on infection, materials, imaging, in vitro models and social sciences;
(b) technical university partners with expertise on material science, imaging, and in vitro and in vivo test models;
(c) university medical centres with expertise on infection, microbiology, in vitro and in vivo models, imaging, animal models, material technology, and clinical studies;
(d) small and large medical device companies and start-up companies with antimicrobial technologies; (e) scientific societies and knowledge institute of medical specialists with direct access to our target audience and patient groups for communication and dissemination;
(f) the Dutch National Institute for Public Health and the Environment (RIVM) with expertise on materials science and Adverse Outcome Pathways (AOPs); and
(g) an international knowledge platform on AMR with expertise on AMR communication.

Project Members

Principal investigator

Chris Arts

Associate Professor Translational Biomaterials
Dr Chris Arts is Associate Professor Translational Biomaterials Research at Departement of Orthopaedic Surgery Maastricht University Medical Centre (MUMC) and Eindhoven University of Technology (Faculty Biomedical Engineering). His Ph.D. thesis at Radboud University Medical Centre Nijmegen (2006) focussed on the usability of calcium phosphate ceramic materials during hip arthroplasty revision surgery with the bone impaction grafting technique.
Chris Arts is working in the field of translational biomaterials research with emphasis on biomaterials for use in (1) bone defect healing, (2) infection prevention and treatment, and (3) spinal deformity treatment. Furthermore he is working on development of high resolution imaging techniques to visualize incorporation, degradation of biomaterials in vivo in clinical patients. 3-D printing of medical devices or implants for bone healing is another one of his research pursuits and currently he is the PI of the Interreg Prosperos research consortium. In conduction with several societies he is active in setting up new initiatives in biomaterials education for both academia and industry.

Chris Arts has co-authored about 75 publications in peer-reviewed international journals and several book chapters. In 2018, he initiated the Translational Orthopaedic Biomaterial Interest Group (TOBIG) to raise more awareness about education relating to use of bone graft substitute materials for bone healing and infection treatment www.tobig.eu

WP Leaders